
Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks
Maribel Rodriguez-Torres, Sugantha Govindarajan, Moises Diago, Thomas Morgan, Bhupinderjit Anand, Karl Barange, Frank Suter, Amy Lin, Gregory Hooper, Mitchell ShiffmanVolume:
29
Année:
2009
Langue:
english
Pages:
5
DOI:
10.1111/j.1478-3231.2008.01859.x
Fichier:
PDF, 194 KB
english, 2009